Pharmafile Logo

CSL Seqirus

- PMLiVE

CSL Seqirus announces strengthened vaccine partnership with UK government

The partnership introduces a world-first flu vaccine and extends the health security pandemic agreement

- PMLiVE

Merck agrees deal with Cidara Therapeutics worth almost $9.2bn

Cidara’s long-acting viral flu drug showed significant protection in phase 2 results

- PMLiVE

Sanofi reports improved patient outcomes from high-dose influenza vaccine

Study data shows a reduced risk of hospitalisation in older adults compared with standard-dose vaccines

- PMLiVE

UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

- PMLiVE

UK government’s AMR study highlights importance of appropriate antibiotic use

The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam

- PMLiVE

Prime minister unveils UK government’s plans to abolish NHS England

The move aims to cut waiting times and free up money for front-line services

- PMLiVE

UK government launches ‘landmark’ AI breast cancer screening trial

Approximately 55,000 cases of the disease are diagnosed every year in the UK

- PMLiVE

UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance

The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year

- PMLiVE

UK government launches £400m investment programme to support clinical research

Up to 18 clinical trial hubs will be created to accelerate the development of new drugs

- PMLiVE

UK government announces national RSV vaccination programme for infants and older adults

The respiratory virus accounts for about 30,000 hospitalisations in children under five every year in the UK

- PMLiVE

UK government launches five-year national action plan for antimicrobial resistance

It is estimated that 1.27 million global deaths in 2019 were caused by antibiotic-resistant infections

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links